Pain Patches Market Trends

  • Report ID: 5783
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT

Pain Patches Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising occurrence of chronic pain - According to estimates, the burden of chronic pain has increased to 1.9 billion people worldwide who suffer from recurrent tension-type headaches, the most common symptom of chronic diseases. Therefore, pain patches are used to treat moderate to severe chronic pain when ongoing pain management is necessary for an extended period. As a result, with the number of cases of chronic and other illness-related pain rises, so the demand for pain patches to help patients with pain relief and support market grow.

  • Rising aged population - As per the World Health Organization, by 2050, the number of individuals over 80 is expected to triple globally, with the age distribution over 65 years increasing to 36%. This is due to both the aging population and the potential for longer lifespans. Given that 80% of nursing homes and 73% of older people who live in communities report suffering pain regularly, there may be a risk of age-related discomfort. Research indicates that not just chronic pain but also acute pain is not well managed in this group of people.

  • Increase in incidence of sport & work-related trauma injuries - In recent years, there has been a sharp increase in the number of people participating in physically demanding sports and jobs and are possibly risky. These elements raise the chances of chronic illnesses like tendinitis and carpal tunnel syndrome as well as acute injuries including fractures, strains, and sprains. There is a direct correlation between the number of people participating in these activities and the risk of injury. There is an increasing need for easy-to-use, non-invasive pain management options as a result of these accidents. By administering medication directly to the site of pain without the need for oral medication or intrusive procedures, pain patches provide a tailored approach to pain management.

Challenges

  • Availability of alternatives - Engaging in physical activities can improve efficiency and standard of life while improving safety and reducing the degree of pain. Patients with complex regional pain syndrome with pain and function (CRPS) have been found to benefit from several physical therapy treatments, including graded motor imagery (GMI) and mirror therapy.

    Additionally, the benefits of GMI and mirror treatment for phantom limb pain were found. As a result, it is anticipated that the availability of various alternative therapies, including chiropractic adjustments, acupuncture, and pain management devices, will reduce the need for pain patches because they have no negative side effects and will prevent the market from growing.

  • Limited efficacy may hinder market growth.
  • Patent expiration in this field may hamper the growth of the market.

Base Year

2024

Forecast Year

2025-2037

CAGR

4.9%

Base Year Market Size (2024)

USD 5.39 billion

Forecast Year Market Size (2037)

USD 10.04 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Pain Patches Market in 2025 is evaluated at USD 5.6 billion.

The global market size crossed USD 5.39 billion in 2024 and is likely to register a CAGR of over 4.9%, exceeding USD 10.04 billion revenue by 2037.

North America is estimated to record USD 3.21 billion by 2037, driven by rising number of people participating in sports and fitness activities, leading to an increased demand for pain relief treatments.

The major players in the market include Endo, Inc., Johnson and Johnson Private Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals LLC, Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Grunenthal GmbH, NEXGEL, Inc., Viatris Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos